Exciting new data showcases a breakthrough in limb salvage, thanks to advancements in Serranator technology. The study, highlighted on April 28, 2026, underscores the impact of the Serranator device in improving outcomes for patients at risk of limb amputation. This innovative approach offers renewed hope for individuals suffering from severe vascular diseases and critical limb ischemia by enhancing blood flow and promoting tissue healing. The Serranator device works by a unique mechanism of action, gently scoring the artery walls and facilitating drug delivery to the affected areas. This method significantly reduces the need for limb amputations, providing patients with an effective alternative treatment option. As this promising technology continues to gain traction, healthcare professionals are optimistic about its potential in transforming vascular and limb-preserving therapies.
BriefGlanceNew data shows AI uptake slow in transport and manufacturing
April 30, 2026
In a recent report released by NAB, it has been revealed that the adoption of artificial intelligence (AI) in the transport and manufacturing sectors is